September 2, 2016
New Developments
Toward a Defense of Mesothelioma Cases on Causation: Low Doses and Genetics
By Mark Zellmer

Today’s defendants in asbestos litigation often face plaintiffs’ claims that they have contracted mesothelioma from exposure to low or even doubtful doses of asbestos. If the mesothelioma looks to be spontaneous (idiopathic) or the result of an exposure so low that it will not cause the disease or the mesothelioma, genetics may provide the alternate explanation to satisfy the jury about why plaintiff or decedent has mesothelioma. [Continue Reading]

California Supreme Court Exercises Personal Jurisdiction Over Pharmaceutical Manufacturer
By Jen Dlugosz

This week the California Supreme Court ruled that Bristol-Myers Squibb (“BMS”) is subject to personal jurisdiction of the California courts on the basis of specific jurisdiction.See Bristol-Myers Squibb Co. v. Superior Court (Anderson), S221038, slip op. (Cal. Aug. 29, 2016). This decision upheld the Court of Appeals decision that found that BMS’s activities in California were “insufficient to subject it to general jurisdiction in the state but that, given the nature of the action and BMS’s activities in California,” California courts may properly exercise specific personal jurisdiction over BMS in this matter. [Continue Reading]

Editor of the Month
Mark Zellmer is a Husch Blackwell partner and handles asbestos litigation throughout the nation and acts as national counsel for various firm clients. Over the last several years, he has concentrated much of his litigation work, publishing and speaking on the subjects of the causation and epidemiology of mesothelioma, lung cancer and asbestosis. He has published and spoken extensively on the asbestos litigation, including concepts of asbestos medicine, the interplay of workers’ compensation and asbestos litigation in civil courts, application of OSHA to asbestos litigation and numerous other topics.
Connect with us: Blog | Twitter | LinkedIn
Technology, Manufacturing & Transportation
Asbestos Practice
Companies face increasingly well‐coordinated attacks in jurisdictions across the country. These assaults are becoming more complex and costly as plaintiffs’ counsel pursue novel theories and claims to keep asbestos litigation thriving. Husch Blackwell’s team has experience in numerous jurisdictions throughout 37 states. Our attorneys can help you navigate the intricate web of plaintiffs’ firms, changing laws, evolving science and anti-defendant courts. [More information]
Upcoming Events
DRI – Asbestos Medicine
November 10-11, 2016
New Orleans, LA

Mark Zellmer will be speaking at this DRI seminar; we hope to see you there!